Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis

Journal of Tropical Medicine

Volumn 2015, Issue , 2015, Pages

  Yakasai, Ahmad M ^a   Hamza, Muhammad ^b   Dalhat, Mahmood M ^b   Bello, Musa ^b   Gadanya, Muktar A ^b   Yaqub, Zuwaira M ^c   Ibrahim, Daiyabu A ^b   Hassan Hanga, Fatimah ^b  

^a Northwest University Kano   (Nigeria)

^b BAYERO UNIVERSITY   (Nigeria)

^c AMINU KANO TEACHING HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ;

ACCURACY; ARTEMISININ BASED COMBINATION THERAPY; CAREGIVER; COMPARATIVE STUDY; DRUG DOSAGE FORM COMPARISON; HUMAN; MALARIA; META ANALYSIS; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PUBLISHING; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNCOMPLICATED MALARIA;

EID: 84935830586     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2015/189232     Document Type: Review

References (58)

1. T. K. Mutabingwa, "Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!," Acta Tropica, vol. 95, no. 3, pp. 305-315, 2005.
2. TanzanianNational Bureau of Statistics, Household Budget Survey, 2001, http://www.nbs.go.tz/tnada/index.php/ddibrowser/1.
3. World Health Organization, "Antimalarial drug combination therapy. Report of aWHOtechnical consultation,"WHO/CDS/RBM 2001. 35, World Health Organization, Geneva, Switzerland, 2001.
4. International Artemisinin Study Group, "Artesunate combinations for treatment of malaria: meta-analysis," The Lancet, vol. 363, no. 9402, pp. 9-17, 2004.
5. S. Y. Whegang, R. Tahar, V. N. Foumane et al., "Efficacy of non-artemisinin-and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon," Malaria Journal, vol. 9, no. 1, article 56, 2010.
6. World Health Organization, Antimalarial Drug Combination Therapy: Report of a Technical Consultation, WHO, Geneva, Switzerland, 2001.
7. A. Bosman and K. N. Mendis, "A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies," American Journal of Tropical Medicine and Hygiene, vol. 77, supplement 6, pp. 193-197, 2007.
8. G. O. Adjei, A. K. Darkwah, B. Q. Goka et al., "Parents perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in Ghana," Ghana Medical Journal, vol. 42, no. 3, pp. 99-106, 2008.
9. K. Yeboah-Antwi, J. O. Gyapong, I. K. Asare, G. Barnish, D. B. Evans, and S. Adjei, "Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment," Bulletin of theWorld Health Organization, vol. 79, no. 5, pp. 394-399, 2001.
10. K. Banek, M. Lalani, S. G. Staedke, and D. Chandramohan, "Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence," Malaria Journal, vol. 13, no. 1, article 7, 2014.
11. K. Bruxvoort, C. Goodman, S. P. Kachur, and D. Schellenberg, "Howpatients take malaria treatment: a systematic reviewof the literature on adherence to antimalarial drugs," PLoS ONE, vol. 9, no. 1, Article IDe84555, 15 pages, 2014.
12. E. O. Onyango, G. Ayodo, C. A. Watsierah et al., "Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya," BMC Infectious Diseases, vol. 12, article 143, 2012.
13. S. H. Downs and N. Black, "The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions," Journal of Epidemiology and Community Health, vol. 52, no. 6, pp. 377-384, 1998.
14. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement," PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009.
15. D. F. Stroup, J. A. Berlin, S. C. Morton et al., "Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group," The Journal of the American Medical Association, vol. 283, no. 15, pp. 2008-2012, 2000.
16. R. DerSimonian and N. Laird, "Meta-analysis in clinical trials," Controlled Clinical Trials, vol. 7, no. 3, pp. 177-188, 1986.
17. C. B. Begg and M. Mazumdar, "Operating characteristics of a rank correlation test for publication bias," Biometrics, vol. 50, no. 4, pp. 1088-1101, 1994.
18. M. Egger, G. D. Smith, M. Schneider, and C. Minder, "Bias in meta-analysis detected by a simple, graphical test," British Medical Journal, vol. 315, no. 7109, pp. 629-634, 1997.
19. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, "Measuring inconsistency in meta-analyses," The British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
20. J. Lau, J. P. A. Ioannidis, N. Terrin, C. H. Schmid, and I. Olkin, "The case of the misleading funnel plot," BritishMedical Journal, vol. 333, no. 7568, pp. 597-600, 2006.
21. A. Tobias, "Assessing the influence of a single study in the metaanyalysis estimate," Stata Technical Bulletin, vol. 8, no. 47, pp. 15-17, 1999.
22. I. O. Ajayi, E. N. Browne, B. Garshong et al., "Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites," Malaria Journal, vol. 7, article 6, 2008.
23. K. P. Asante, R. Owusu, D. Dosoo et al., "Adherence to artesunate-amodiaquine therapy for uncomplicated malaria in rural ghana: a randomised trial of supervised versus unsupervised drug administration," Journal of Tropical Medicine, vol. 2009, Article ID529583, 7 pages, 2009.
24. H. Lawford, D. Zurovac, L. OReilly et al., "Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya," Malaria Journal, vol. 10, article 281, 2011.
25. A. M. Kabanywanyi, C. Lengeler, P. Kasim et al., "Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania," Malaria Journal, vol. 9, no. 1, article 48, 2010.
26. S. Gerstl, S. Dunkley, A. Mukhtar, S. Baker, and J. Maikere, "Successful introduction of artesunate combination therapy is not enough to fight malaria: results from an adherence study in Sierra Leone," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 104, no. 5, pp. 328-335, 2010.
27. N. Beer, A. S. Ali, G. Rotllant et al., "Adherence to artesunateamodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania," Tropical Medicine and International Health, vol. 14, no. 7, pp. 766-774, 2009.
28. D. J. Bell, D. Wootton, M. Mukaka et al., "Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi," Malaria Journal, vol. 8, no. 1, article 204, 2009.
29. H. Lemma, C. Lofgren, and M. S. Sebastian, "Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia," Malaria Journal, vol. 10, article 349, 2011.
30. K. E. Mace, D. Mwandama, J. Jafali et al., "Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in Rural Malawi," Clinical Infectious Diseases, vol. 53, no. 8, pp. 772-779, 2011.
31. C. Fogg, F. Bajunirwe, P. Piola et al., "Adherence to a sixdose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda," American Journal of Tropical Medicine and Hygiene, vol. 71, no. 5, pp. 525-530, 2004.
32. S. P. Kachur, R. A. Khatib, E. Kaizer, S. S. Fox, S. M. Abdulla, and P. B. Bloland, "Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania," American Journal of Tropical Medicine and Hygiene, vol. 71, no. 6, pp. 715-722, 2004.
33. E. Depoortere, J.-P. Guthmann, N. Sipilanyambe et al., "Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in theMaheba refugee settlement, Zambia," Tropical Medicine and International Health, vol. 9, no. 1, pp. 62-67, 2004.
34. A. M. Chinbuah, J. O. Gyapong, F. Pagnoni, E. K. Wellington, and M. Gyapong, "Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana," Tropical Medicine and International Health, vol. 11, no. 7, pp. 1003-1016, 2006.
35. D. O. Simba, D. Kakoko, G. Tomson et al., "Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 106, no. 1, pp. 3-9, 2012.
36. J. L. Cohen, E. Yavuz, A. Morris, J. Arkedis, and O. Sabot, "Do patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Uganda," Malaria Journal, vol. 11, article 83, 2012.
37. J. Achan, J. K. Tibenderana, D. Kyabayinze et al., "Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial," BritishMedical Journal, vol. 339, Article ID b2763, pp. 1-8, 2009.
38. A. O. Amponsah, H. Vosper, and A. F. A. Marfo, "Patient related factors affecting adherence to antimalarial medication in an urban estate in Ghana," Malaria Research and Treatment, vol. 2015, Article ID 452539, 8 pages, 2015.
39. W. Aung, A. M. Dondorp, M. Min et al., "Assessment of adherence to three day course of artemeter-lumefantrine treatment in Rhakine state, Myanmar," JITMM Proceedings 3, vol. 4, pp. 16-23, 2015.
40. K. Bruxvoort, A. Kalolella, M. Cairns et al., "Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?" Malaria Journal, vol. 14, no. 1, pp. 1-12, 2015.
41. K. Congpuong, P. Bualombai, V. Banmairuroi, and K. Na-Bangchang, "Compliancewith a three-day course of artesunatemefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparummalaria," Malaria Journal, vol. 9, article 43, pp. 2-8, 2010.
42. V. L. Ewing, D. J. Terlouw, A. Kapinda et al., "Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa district ofMalawi: a mixed methods study,"Malaria Journal, vol. 14, article 13, pp. 2-10, 2015.
43. G. R. Gore-Langton, N. Alenwi, J. Mungai et al., "Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting," Malaria Journal, vol. 14, no. 1, article 125, 10 pages, 2015.
44. M. R. Siddiqui, A. Willis, K. Bil, J. Singh, E. Mukomena Sompwe, and C. Ariti, "Adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Democratic Republic of the Congo," F1000Research, vol. 4, no. 51, pp. 1-16, 2015.
45. J. O. Ogolla, S. O. Ayaya, and C. A. Otieno, "Levels of adherence to coartem in the routine treatment of uncomplicated malaria in children aged below five years, in Kenya," Iranian Journal of Public Health, vol. 42, no. 2, pp. 129-133, 2013.
46. J. Nankabirwa, D. Zurovac, J. N. Njogu et al., "Malaria misdiagnosis in Uganda-implications for policy change," Malaria Journal, vol. 8, no. 1, article 66, 2009.
47. A. K. Mbonye, S. Lal, B. Cundill, K. S. Hansen, S. Clarke, and P. Magnussen, "Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops inUganda," Malaria Journal, vol. 12, no. 1, article 131, 2013.
48. N. J. White and W. Pongtavornpinyo, "The de novo selection of drug-resistant malaria parasites," Proceedings of the Royal Society B: Biological Sciences, vol. 270, no. 1514, pp. 545-554, 2003.
49. J. Armstrong-Schellenberg, C. G. Victora, A. Mushi et al., "Inequities among the very poor: health care for children in rural southern Tanzania," The Lancet, vol. 361, no. 9357, pp. 561-566, 2003.
50. S. Toovey and A. Jamieson, "Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 98, no. 5, pp. 261-267, 2004.
51. S. Yeung, W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White, "Antimalarial drug resistance, artemisininbased combination therapy, and the contribution of modeling to elucidating policy choices," American Journal of Tropical Medicine and Hygiene, vol. 71, supplement 2, pp. 179-186, 2004.
52. G. M. L. Nayyar, J. G. Breman, P. N. Newton, and J. Herrington, "Poor-quality antimalarial drugs in Southeast Asia and sub-Saharan Africa," The Lancet Infectious Diseases, vol. 12, no. 6, pp. 488-496, 2012.
53. M. Makanga, Z. Premji, C. Falade et al., "Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data,"AmericanJournal of Tropical Medicine and Hygiene, vol. 74, no. 6, pp. 991-998, 2006.
54. A. M. Dondorp, S. Yeung, L. White et al., "Artemisinin resistance: current status and scenarios for containment," Nature Reviews Microbiology, vol. 8, no. 4, pp. 272-280, 2010.
55. A. M. Dondorp, F. Nosten, P. Yi et al., "Artemisinin resistance in Plasmodium falciparum malaria," The New England Journal of Medicine, vol. 361, no. 5, pp. 455-467, 2009.
56. I. M. Hastings and W. M. Watkins, "Intensity of malaria transmission and the evolution of drug resistance," Acta Tropica, vol. 94, no. 3, pp. 218-229, 2005.
57. A. O. Talisuna, P. Langi, N. Bakyaita et al., "Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?" Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 3, pp. 310-317, 2002.
58. M. Twagirumukiza, P. C. Kayumba, J. G. Kips et al., "Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants," Malaria Journal, vol. 9, no. 1, article 206, 2010.